Cargando…

Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study

BACKGROUND: FMF2012 is an algorithm developed by the Fetal Medicine Foundation (FMF) to predict pre-eclampsia on the basis of maternal characteristics combined with biophysical and biochemical markers. Afro-Caribbean ethnicity is the second risk factor, in magnitude, found in populations tested by F...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezende, Karina Bilda De Castro, Cunha, Antonio José Ledo Alves, Amim Jr, Joffre, Oliveira, Wescule De Moraes, Leão, Maria Eduarda Belloti, Menezes, Mariana Oliveira Alves, Jardim, Ana Alice Marques Ferraz De Andrade, Bornia, Rita Guérios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898886/
https://www.ncbi.nlm.nih.gov/pubmed/31755874
http://dx.doi.org/10.2196/14738
_version_ 1783477048854970368
author Rezende, Karina Bilda De Castro
Cunha, Antonio José Ledo Alves
Amim Jr, Joffre
Oliveira, Wescule De Moraes
Leão, Maria Eduarda Belloti
Menezes, Mariana Oliveira Alves
Jardim, Ana Alice Marques Ferraz De Andrade
Bornia, Rita Guérios
author_facet Rezende, Karina Bilda De Castro
Cunha, Antonio José Ledo Alves
Amim Jr, Joffre
Oliveira, Wescule De Moraes
Leão, Maria Eduarda Belloti
Menezes, Mariana Oliveira Alves
Jardim, Ana Alice Marques Ferraz De Andrade
Bornia, Rita Guérios
author_sort Rezende, Karina Bilda De Castro
collection PubMed
description BACKGROUND: FMF2012 is an algorithm developed by the Fetal Medicine Foundation (FMF) to predict pre-eclampsia on the basis of maternal characteristics combined with biophysical and biochemical markers. Afro-Caribbean ethnicity is the second risk factor, in magnitude, found in populations tested by FMF, which was not confirmed in a Brazilian setting. OBJECTIVE: This study aimed to analyze the performance of pre-eclampsia prediction software by customization of maternal ethnicity. METHODS: This was a cross-sectional observational study, with secondary evaluation of data from FMF first trimester screening tests of singleton pregnancies. Risk scores were calculated from maternal characteristics and biophysical markers, and they were presented as the risk for early pre-eclampsia (PE34) and preterm pre-eclampsia (PE37). The following steps were followed: (1) identification of women characterized as black ethnicity; (2) calculation of early and preterm pre-eclampsia risk, reclassifying them as white, which generated a new score; (3) comparison of the proportions of women categorized as high risk between the original and new scores; (4) construction of the receiver operator characteristic curve; (5) calculation of the area under the curve, sensitivity, and false positive rate; and (6) comparison of the area under the curve, sensitivity, and false positive rate of the original with the new risk by chi-square test. RESULTS: A total of 1531 cases were included in the final sample, with 219 out of 1531 cases (14.30; 95% CI 12.5-16.0) and 182 out of 1531 cases (11.88%; 95% CI 10.3-13.5) classified as high risk for pre-eclampsia development, originally and after recalculating the new risk, respectively. The comparison of FMF2012 predictive model performance between the originally estimated risks and the estimated new risks showed that the difference was not significant for sensitivity and area under the curve, but it was significant for false positive rate. CONCLUSIONS: We conclude that black ethnicity classification of Brazilian pregnant women by the FMF2012 algorithm increases the false positive rate. Suppressing ethnicity effect did not improve the test sensitivity. By modifying demographic characteristics, it is possible to improve some performance aspects of clinical prediction tests.
format Online
Article
Text
id pubmed-6898886
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-68988862019-12-23 Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study Rezende, Karina Bilda De Castro Cunha, Antonio José Ledo Alves Amim Jr, Joffre Oliveira, Wescule De Moraes Leão, Maria Eduarda Belloti Menezes, Mariana Oliveira Alves Jardim, Ana Alice Marques Ferraz De Andrade Bornia, Rita Guérios J Med Internet Res Original Paper BACKGROUND: FMF2012 is an algorithm developed by the Fetal Medicine Foundation (FMF) to predict pre-eclampsia on the basis of maternal characteristics combined with biophysical and biochemical markers. Afro-Caribbean ethnicity is the second risk factor, in magnitude, found in populations tested by FMF, which was not confirmed in a Brazilian setting. OBJECTIVE: This study aimed to analyze the performance of pre-eclampsia prediction software by customization of maternal ethnicity. METHODS: This was a cross-sectional observational study, with secondary evaluation of data from FMF first trimester screening tests of singleton pregnancies. Risk scores were calculated from maternal characteristics and biophysical markers, and they were presented as the risk for early pre-eclampsia (PE34) and preterm pre-eclampsia (PE37). The following steps were followed: (1) identification of women characterized as black ethnicity; (2) calculation of early and preterm pre-eclampsia risk, reclassifying them as white, which generated a new score; (3) comparison of the proportions of women categorized as high risk between the original and new scores; (4) construction of the receiver operator characteristic curve; (5) calculation of the area under the curve, sensitivity, and false positive rate; and (6) comparison of the area under the curve, sensitivity, and false positive rate of the original with the new risk by chi-square test. RESULTS: A total of 1531 cases were included in the final sample, with 219 out of 1531 cases (14.30; 95% CI 12.5-16.0) and 182 out of 1531 cases (11.88%; 95% CI 10.3-13.5) classified as high risk for pre-eclampsia development, originally and after recalculating the new risk, respectively. The comparison of FMF2012 predictive model performance between the originally estimated risks and the estimated new risks showed that the difference was not significant for sensitivity and area under the curve, but it was significant for false positive rate. CONCLUSIONS: We conclude that black ethnicity classification of Brazilian pregnant women by the FMF2012 algorithm increases the false positive rate. Suppressing ethnicity effect did not improve the test sensitivity. By modifying demographic characteristics, it is possible to improve some performance aspects of clinical prediction tests. JMIR Publications 2019-11-22 /pmc/articles/PMC6898886/ /pubmed/31755874 http://dx.doi.org/10.2196/14738 Text en ©Karina Bilda De Castro Rezende, Antonio José Ledo Alves Cunha, Joffre Amim Jr, Wescule De Moraes Oliveira, Maria Eduarda Belloti Leão, Mariana Oliveira Alves Menezes, Ana Alice Marques Ferraz De Andrade Jardim, Rita Guérios Bornia. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 22.11.2019. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Rezende, Karina Bilda De Castro
Cunha, Antonio José Ledo Alves
Amim Jr, Joffre
Oliveira, Wescule De Moraes
Leão, Maria Eduarda Belloti
Menezes, Mariana Oliveira Alves
Jardim, Ana Alice Marques Ferraz De Andrade
Bornia, Rita Guérios
Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study
title Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study
title_full Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study
title_fullStr Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study
title_full_unstemmed Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study
title_short Performance of Fetal Medicine Foundation Software for Pre-Eclampsia Prediction Upon Marker Customization: Cross-Sectional Study
title_sort performance of fetal medicine foundation software for pre-eclampsia prediction upon marker customization: cross-sectional study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898886/
https://www.ncbi.nlm.nih.gov/pubmed/31755874
http://dx.doi.org/10.2196/14738
work_keys_str_mv AT rezendekarinabildadecastro performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy
AT cunhaantoniojoseledoalves performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy
AT amimjrjoffre performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy
AT oliveirawesculedemoraes performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy
AT leaomariaeduardabelloti performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy
AT menezesmarianaoliveiraalves performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy
AT jardimanaalicemarquesferrazdeandrade performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy
AT borniaritaguerios performanceoffetalmedicinefoundationsoftwareforpreeclampsiapredictionuponmarkercustomizationcrosssectionalstudy